rostafuroxin has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hoai Nguyen, BC; Jeong, JH; Kim, DJ; Kim, HC; Lichtstein, D; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ; Tran, NKC | 1 |
| Bianchi, G; Ferrandi, M; Ferrari, P; Manunta, P; Molinari, I; Rastaldi, MP | 1 |
| Ferrari, P | 1 |
1 review(s) available for rostafuroxin and Disease Models, Animal
| Article | Year |
|---|---|
Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
Topics: Androstanols; Animals; Antihypertensive Agents; Blood Pressure; Calmodulin-Binding Proteins; Clinical Trials, Phase II as Topic; Disease Models, Animal; ErbB Receptors; Humans; Hypertension; Kidney; Mutation; Ouabain; Polymorphism, Genetic; Signal Transduction; Sodium; Sodium-Potassium-Exchanging ATPase; src-Family Kinases | 2010 |
2 other study(ies) available for rostafuroxin and Disease Models, Animal
| Article | Year |
|---|---|
Ouabain inhibitor rostafuroxin attenuates dextromethorphan-induced manic potential.
Topics: Androstanols; Animals; Bipolar Disorder; Dextromethorphan; Disease Models, Animal; Locomotion; Male; Mice; Ouabain; Signal Transduction | 2021 |
Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.
Topics: Androstanols; Animals; Antihypertensive Agents; Calmodulin-Binding Proteins; Disease Models, Animal; Female; Genetic Variation; Hypertension; Kidney; Male; Mice; Mice, Knockout; Ouabain; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2014 |